IL‐13 production by allergen‐stimulated T cells is increased in allergic disease and associated with IL‐5 but not IFN‐γ expression
- 1 May 1997
- journal article
- Published by Wiley in Immunology
- Vol. 91 (1) , 53-57
- https://doi.org/10.1046/j.1365-2567.1997.00218.x
Abstract
Interleukin‐13 (IL‐13) shares many, but not all, of the properties of the prototypic T‐helper type 2 (Th2) cytokine IL‐4, but its role in allergen‐driven T‐cell responses remains poorly defined. We hypothesized that allergen stimulation of peripheral blood T cells from patients with atopic disease compared with non‐atopic controls results in elevated IL‐13 synthesis in the context of a ‘Th2‐type’ pattern. Freshly isolated peripheral blood mononuclear cells (PBMC) obtained from sensitized atopic patients with allergic disease, and non‐atopic control subjects, were cultured with the allergens Phleum pratense (Timothy grass pollen) or Dermatophagoides pteronyssinus (house dust mite) and the non‐allergenic recall antigen Mycobacterium tuberculosis purified protein derivative (PPD). Supernatant concentrations of IL‐13, along with IL‐5 and interferon‐γ (IFN‐γ) (Th2‐ and Th1‐type cytokines, respectively) were determined by enzyme‐linked immunosorbent assay (ELISA). Allergen‐induced IL‐13 and IL‐5 production by T cells from patients with allergic disease was markedly elevated (P=0·0075 and P=0·0004, respectively) compared with non‐atopic controls, whereas IFN‐γ production was not significantly different. In contrast to allergen, the prototypic Th1‐type antigen M. tuberculosis PPD induced an excess of IFN‐γ over IL‐13 and IL‐5 production, and absolute concentrations of cytokines were not affected by the presence or absence of atopic disease. Addition of exogenous recombinant IFN‐γ or IL‐12, cytokines known to inhibit Th2‐type responses, significantly inhibited allergen‐driven production of both IL‐13 and IL‐5, but not T‐cell proliferation, whereas exogenous IL‐4 did not significantly affect production of IL‐13 or IL‐5. We conclude that allergen‐specific T cells from atopic subjects secrete elevated quantities of IL‐13 compared with non‐atopic controls, in the context of a Th2‐type pattern of cytokine production.Keywords
This publication has 23 references indexed in Scilit:
- Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cellsInternational Immunology, 1995
- Activated mast cells produce interleukin 13.The Journal of Experimental Medicine, 1995
- Immunoregulatory Properties of IL-13: Its Potential Role in Atopic DiseaseInternational Archives of Allergy and Immunology, 1995
- Enhanced detection of human IL-5 in biological fluids utilizing murine monoclonal antibodies which delineate distinct neutralizing epitopesCytokine, 1994
- Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous responses.Journal of Clinical Investigation, 1993
- Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells.The Journal of Experimental Medicine, 1993
- lnterleukin-13 is a new human lymphokine regulating inflammatory and immune responsesNature, 1993
- Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic AsthmaNew England Journal of Medicine, 1992
- Expression of Interleukin 5 by the CD4+CD45R0+ Subset of Human T CellsGrowth Factors, 1992
- Purified protein derivative of Mycobacterium tuberculosis and excretory-secretory antigen(s) of Toxocara canis expand in vitro human T cells with stable and opposite (type 1 T helper or type 2 T helper) profile of cytokine production.Journal of Clinical Investigation, 1991